About Dr Georgia Arentz

Georgia obtained a PhD from the University of Adelaide for a study in the proteomic and molecular analysis of colorectal cancer. Following her PhD she worked at Flinders Medical Centre where she developed a mass spectrometric protein sequencing protocol for certain types of human auto-antibodies which was the basis for the development of a novel mass spectrometry based diagnostic test for autoimmune diseases.

Georgia now joins the University of South Australia research team where she is working on a project which aims to identify the proteins responsible for chemotherapy resistance in ovarian cancer. The aim is to develop a novel diagnostic test to be able to identify ovarian cancer patients who are resistant to standard chemotherapy regimens, enabling oncologists to personalise treatment and to improve survival.